Orthobiologics Market to Grow with a CAGR of 5.10% through 2030F
Rising prevalence of road accidents are expected to drive
the Global Orthobiologics Market in the forecast period 2026-2030F
According to TechSci Research report, “Orthobiologics Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Orthobiologics Market
stood at USD 5.89 billion in 2024 and is anticipated to grow with a CAGR of
5.10% in the forecast period. The significant growth drivers of the
orthobiologics market include a rising incidence of sports injuries, road
accidents, osteoarthritis, and an increasing preference for minimally invasive
surgical approaches.
The global increase in the aging population and the
prevalence of obesity are contributing to a higher incidence of osteoarthritis
and musculoskeletal disorders. The World Health Organization reported that in
2021, around 1.71 billion people worldwide had musculoskeletal conditions. Low
back pain, in particular, had the highest prevalence, affecting 568 million
individuals. In the United Kingdom, more than 20 million people, approximately
one-third of the population, live with musculoskeletal conditions such as
arthritis and low back pain. These conditions significantly impact the quality
of life and contribute to the burden of illness and disability. With the
growing number of musculoskeletal injuries, there is a corresponding rise in
demand for orthobiologics, which is expected to fuel market growth. The
introduction of new orthobiologic products and strategic initiatives by key
market players is anticipated to further boost market expansion. For instance,
Ventris Medical launched Allocell AF in April 2021, a next generation
osteoinductive fiber allograft designed to enhance intra-operative handling and
improve biological responsiveness at the site of injury. However, the high cost
associated with biologic-based treatments and the preference for alternative
therapies pose potential hindrances to market growth.
Orthobiologics refer to a category of biological substances
or materials that are used to promote the healing, regeneration, or replacement
of musculoskeletal tissues, such as bones, cartilage, tendons, and ligaments.
These materials are derived from natural sources or can be produced
synthetically and are utilized in orthopedic and musculoskeletal medicine to
treat a range of conditions and injuries. Here are some key applications of
orthobiologics: Bone Grafting: Orthobiologics are often employed in bone grafting
procedures to stimulate bone growth and repair. Autologous bone grafts (taken
from the patient's own body), allografts (from donors), or synthetic bone
substitutes can be augmented with orthobiologics like growth factors, stem
cells, or bone morphogenetic proteins (BMPs) to enhance the fusion and healing
of fractured or damaged bones. Cartilage Repair: Orthobiologics play a crucial
role in the treatment of cartilage injuries and degenerative conditions like
osteoarthritis. They can be used in conjunction with procedures like
microfracture, autologous chondrocyte implantation (ACI), or osteochondral
grafting to stimulate cartilage regeneration and reduce pain. Tendon and
Ligament Repair: Orthobiologics, particularly platelet-rich plasma (PRP), are applied
in the management of tendon and ligament injuries. PRP injections can promote
tissue healing, reduce inflammation, and enhance the recovery of structures
like the Achilles tendon or anterior cruciate ligament (ACL). Spinal Fusion:
Orthobiologics are frequently utilized in spinal fusion surgeries to stimulate
bone growth and facilitate the fusion of vertebrae. BMPs, in particular, have
been approved for this application, reducing the need for traditional bone
grafts. Soft Tissue Repair: Injuries to soft tissues like tendons and ligaments
can benefit from orthobiologic treatments. These substances can enhance the
healing process, reduce pain, and improve function following injuries.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Orthobiologics Market”
The Global Orthobiologics Market is segmented into product,
application, end user, regional distribution, and company.
Based on product, Viscosupplementation Products dominated the
global orthobiologics market. This is primarily due to their widespread use in
managing osteoarthritis, particularly knee osteoarthritis, which affects
millions globally. Viscosupplementation involves injecting hyaluronic acid into
the joint to improve lubrication, reduce pain, and enhance mobility. Its
minimally invasive nature, quick recovery time, and ability to delay or reduce
the need for joint replacement surgeries make it a preferred treatment option.
The growing aging population and increasing incidence of joint disorders
further drive demand. The ongoing improvements in hyaluronic acid formulations
and delivery methods have enhanced product efficacy and patient outcomes. These
factors collectively contribute to the strong market position and continued
growth of viscosupplementation products within the orthobiologics landscape.
Based on region, Asia-Pacific is the fastest-growing region in the global
orthobiologics market due to several key factors. Rapidly aging populations in
countries like Japan and China are leading to a surge in musculoskeletal
disorders, including osteoarthritis and spinal conditions. The rising
healthcare awareness and increased access to advanced medical treatments are
boosting demand for orthobiologic therapies. Governments across the region are
investing heavily in healthcare infrastructure, while medical tourism is
flourishing due to lower treatment costs and improving quality of care. The
growing adoption of minimally invasive procedures, expanding orthopedic
research, and an increasing number of trained specialists are fueling market
growth. These combined factors make Asia-Pacific a hotspot for innovation and
expansion in the orthobiologics sector.
Major companies operating in Global Orthobiologics
Market are:
· Sanofi
SA
· Stryker
Corporation
· Zimmer
Biomet
· Seaspine
Holdings Corporation
· Medtronic
PLC
· DePuy
Synthes
· Bioventrus
· Globus
Medical
· Arthrex
Limited
· Orthofix
International
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The Global Orthobiologics Market is driven by several
compelling factors that collectively contribute to its rapid growth and
innovation in the healthcare industry. The growing prevalence of
musculoskeletal disorders such as osteoarthritis, osteoporosis, and
sports-related injuries is a significant driver. As the global population ages
and lifestyles become more sedentary, the demand for orthobiologic treatments
to alleviate pain and restore function is on the rise, propell the growth of
Global Orthobiologics Market. The rise in sports participation and athletic
activities has led to a higher incidence of sports-related injuries, including
ligament tears and cartilage damage. Orthobiologics, especially when combined
with minimally invasive procedures, are increasingly used to treat athletes and
active individuals, driving market growth contributes to foster the demand for
Global Orthobiologics Market in the forecast period”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Orthobiologics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Viscosupplementation
Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone
Morphogenic Protein, Allografts, and Others), By Application (Osteoarthritis
and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, and Others),
By End User (Hospitals, Orthopedic Clinics, and Ambulatory Care Centers,
Academic and Research Institutes, and Dental Clinics and Facilities), By Region
& Competition 2020-2030F” has evaluated the future growth
potential of Global Orthobiologics Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Orthobiologics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com